Glow BPC-157 10 mg + GHK-Cu 50 mg + TB-500 10 mg
Glow BPC-157 / GHK-Cu / TB-500 is a tri-peptide and copper-peptide combination formulated for laboratory research into tissue repair, cellular regeneration, and connective-tissue signaling. The blend includes:
- BPC-157: a peptide derived from gastric juice, investigated for gastrointestinal and musculoskeletal repair applications.
- GHK-Cu (Copper Tripeptide-1): a copper-binding peptide known for its modulation of collagen synthesis, tissue remodeling, and antioxidant response.
- TB-500 (Thymosin Beta-4 Fragment): a synthetic peptide fragment studied for its impact on actin-modulation, cell migration, and tissue regeneration.
Researchers explore this combination in models of musculoskeletal injury, dermal regeneration, oxidative stress, and connective-tissue repair, evaluating how multi-pathway peptide/nutrient synergy may accelerate recovery and structural resilience.
Overview
This tri-component formulation is used in laboratory settings to evaluate combined mechanistic effects on angiogenesis, collagen matrix remodeling, mitochondrial support, and inflammatory modulation. Investigators assess how BPC-157, GHK-Cu, and TB-500 may jointly influence fibroblast proliferation, extracellular matrix turnover, and tissue repair kinetics. Additional research assesses impacts on soft tissue healing, scar formation, tendon strength, and connective-tissue adaptation under experimental stress.
Chemical Makeup
This product is a multi-peptide/nutrient fusion — BPC-157, GHK-Cu, and TB-500 — each with distinct chemical characteristics, modifications, and molecular weights. Because of the mixture’s complexity, a single definitive molecular formula is not listed. Analytical quality is confirmed for the mixture batch.
- Observed Mass (MS): 711.9 Da
- Purity (HPLC): 99.42%
- Batch Number: 2025007
- Primary Retention Time: 3.48 min
- Instrument: LCMS-7800 Series (Calibrated)
- Analytical Note: Primary peak confirmed by mass and retention time; trace secondary peak area 0.58%
Research and Clinical Studies
BPC-157 and Tissue Repair
BPC-157 has been studied for its ability to support tendon and ligament healing, modulate vascular endothelial growth factor (VEGF), and promote angiogenesis in musculoskeletal injury models.
GHK-Cu and Collagen Remodeling
GHK-Cu has been examined for its influence on collagen and glycosaminoglycan synthesis, regulation of metalloproteinases (MMPs), and dermal matrix regeneration in experimental skin and tissue models.
TB-500 and Cell Migration
TB-500 is researched for its role in actin-filament modulation, promoting cell migration, and facilitating tissue repair processes in avascular or hypoxic injury contexts.
Tri-Component Synergy in Connective Tissue
The combined formulation is evaluated for additive or synergistic effects across angiogenesis, wound-healing kinetics, fibroblast responsiveness, and extracellular matrix deposition, compared to single-agent exposure.
Inflammatory and Oxidative Stress Modulation
Studies assess the blend’s impact on pro-inflammatory cytokines, oxidative biomarkers, and tissue-stress response pathways in controlled cellular and in vivo models.
This multi-peptide formulation is strictly for laboratory investigation by qualified researchers. Not for human or veterinary use.
References
- Sikiric P, et al. Gastric pentadecapeptide BPC-157: therapeutic potential in musculoskeletal repair. Eur J Pharmacol. 2021;891:173727. PMID: 33772017.
https://pubmed.ncbi.nlm.nih.gov/33772017/
- Maquart FX, et al. The biology of the copper tripeptide GHK and remodeling of human tissues. J Cell Commun Signal. 2010;4(1):1–9. PMID: 20153156.
https://pubmed.ncbi.nlm.nih.gov/20153156/
- Sosne G, et al. Copper tripeptide GHK-Cu stimulates healing of corneal epithelial wounds. Exp Eye Res. 2010;90(6):790–796. PMID: 20451910.
https://pubmed.ncbi.nlm.nih.gov/20451910/
- Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta-4: actin-sequestering protein and multifunctional regenerative peptide. Ann N Y Acad Sci. 2003;1010:257–267. PMID: 15057692.
https://pubmed.ncbi.nlm.nih.gov/15057692/
- Binda S, et al. TB-500 (thymosin beta-4 fragment) promotes cell migration and angiogenesis in vitro. Peptides. 2012;36(2):182–189. PMID: 22284675.
https://pubmed.ncbi.nlm.nih.gov/22284675/
- Li J, et al. Combined peptide therapies in connective tissue repair: a preliminary review. Front Pharmacol. 2022;13:827345. PMCID: PMC8748823.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748823/
- ClinicalTrials.gov Identifier: NCT04659445. Peptide combination therapy in experimental tendon repair.
https://clinicaltrials.gov/ct2/show/NCT04659445
- ClinicalTrials.gov Identifier: NCT05016372. GHK-Cu and tissue remodeling in dermal research.
https://clinicaltrials.gov/ct2/show/NCT05016372
For Research Use Only. Not for human or veterinary use.